Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00315471 · ClinicalTrials.gov registry record

Determining Disease Activity Biomarkers in Individuals With Takayasu's Arteritis

A clinical trial of Takayasu's Arteritis, sponsored by University of Pennsylvania.

Completed
Registry status
224
Enrollment target
9
Study locations

NCT00315471 is a study of Takayasu's Arteritis that has completed, run by University of Pennsylvania. The registered enrollment target is 224 participants, below the 1,451-participant average among 4 other Takayasu's Arteritis trials with a reported enrollment target (85% lower). The trial reports 9 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00315471, a study of Takayasu's Arteritis, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
224 participants
Enrollment target
9
Study locations

Study Summary

Takayasu's arteritis is a rare disorder that causes swelling and damage to the large arteries in the body, such as the aorta. In order to ensure proper treatment, measuring disease activity is critical. The purpose of this study is to establish new biological markers (biomarkers) to assess the severity of disease in people with Takayasu's arteritis.

Conditions Studied

Study Locations (9)

Massachusetts

  • Brigham and Women's Hospital - Boston
  • Boston University School of Medicine - Boston

Pennsylvania

  • University of Pennsylvania - Philadelphia
  • University of Pittsburgh - Pittsburgh

Ontario

  • St. Joseph's Healthcare - Hamilton
  • Mount Sinai Hospital - Toronto

Minnesota

  • Mayo Clinic College of Medicine - Rochester

Ohio

  • Cleveland Clinic Foundation - Cleveland

Utah

  • University of Utah - Salt Lake City

Trial Details

FieldValue
Enrollment Target 224 participants
Start Date 2006-04
Est. Completion 2019-12

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT00315471

The ClinicalTrials.gov registry entry for NCT00315471 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 224 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,451-participant average among 4 other Takayasu's Arteritis trials with a reported enrollment target (85% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Takayasu's Arteritis appearing as the primary indexed condition, and to 0 interventions.

NCT00315471 reports 9 study locations spanning 6 distinct geographic areas - top geographies include Massachusetts, Pennsylvania, Ontario.

Frequently Asked Questions

What is clinical trial NCT00315471 about?

NCT00315471 is a clinical study titled "Determining Disease Activity Biomarkers in Individuals With Takayasu's Arteritis". Takayasu's arteritis is a rare disorder that causes swelling and damage to the large arteries in the body, such as the aorta. In order to ensure proper treatment, measuring disease activity is critical. The purpose of this study is to establish new biological markers (biomarkers) to assess the sever...

What is the current status of trial NCT00315471?

This trial is currently completed. The enrollment target is 224 participants. The study started on 2006-04. Estimated completion is 2019-12.

What conditions does trial NCT00315471 study?

This clinical trial studies the following conditions: Takayasu's Arteritis.

Who is sponsoring clinical trial NCT00315471?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00315471 being conducted?

This trial has 9 study locations across Massachusetts, Minnesota, Ohio, Pennsylvania, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Takayasu's Arteritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.